A Study to Test How Insulin NNC0471-0119 H Works in the Body in Participants With Type 2 Diabetes When Given by an Insulin Pump

This study is testing how a new experimental long-acting insulin (NNC0471-0119 H) behaves when delivered through an insulin pump in people with type 2 diabetes — examining how it is absorbed, circulates in the bloodstream, and clears from the body compared to standard insulins. This helps determine the correct dosing and safety profile before broader testing. **You may be eligible if...** - You are 18 to 69 years old - You have been diagnosed with type 2 diabetes for at least 6 months - You have been using injectable insulin for at least 6 months at a consistent dose - Your long-term blood sugar marker (HbA1c) is 9.5% or below - Your body mass index (BMI) is between 18.5 and 34.9 - You are NOT currently using a once-weekly insulin formulation **You may NOT be eligible if...** - You have a known allergy to the study drug or similar insulins - You are pregnant, breastfeeding, or planning to become pregnant Talk to your doctor to see if this trial is right for you.